Skip to main content
Erschienen in: Annals of Hematology 1/2011

01.01.2011 | Original Article

Molecular characterization of a novel 27.6-kb deletion causing α+ thalassemia in a Chinese family

verfasst von: Xiao-Feng Wei, Xuan Shang, De-Qin He, Ji-Wei Huang, Xin-Hua Zhang, Xiang-Min Xu

Erschienen in: Annals of Hematology | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Over 80% of the α-thalassemia cases in southern China are caused by large deletions involving the α-globin gene cluster on chromosome 16p13.3. Here, we characterized a novel 27.6-kb deletion on the α-globin gene cluster in a Chinese family. Its breakpoints were detected to lie between coordinates 9079 and 36718 of the α-globin gene cluster (NG_000006.1), with a total of 27,640 nucleotides deleted. It was designated as −α 27.6 deletion. The proband is a compound heterozygote of −−SEA and −α 27.6 and he displayed very mild hemoglobin H disease phenotype with Hb 7.9–9.3 g/dl. Phenotypic analysis on heterozygote of this deletion revealed it as α+ mutation. It leads to a very mild phenotype as adult heterozygotes have normal hematological parameters with the values at the lower border of the normal range. RT-PCR analysis showed that the α-globin mRNA level of the heterozygotes was decreased when compared with that of normal people.
Literatur
1.
Zurück zum Zitat Xu XM, Zhou YQ, Luo GX, Liao C, Zhou M, Chen PY, Lu JP, Jia SQ, Xiao GF, Shen X, Li J, Chen HP, Xia YY, Wen YX, Mo QH, Li WD, Li YY, Zhuo LW, Wang ZQ, Chen YJ, Qin CH, Zhong M (2004) The prevalence and spectrum of alpha and beta thalassaemia in Guangdong Province: implications for the future health burden and population screening. J Clin Pathol 57:517–522CrossRefPubMed Xu XM, Zhou YQ, Luo GX, Liao C, Zhou M, Chen PY, Lu JP, Jia SQ, Xiao GF, Shen X, Li J, Chen HP, Xia YY, Wen YX, Mo QH, Li WD, Li YY, Zhuo LW, Wang ZQ, Chen YJ, Qin CH, Zhong M (2004) The prevalence and spectrum of alpha and beta thalassaemia in Guangdong Province: implications for the future health burden and population screening. J Clin Pathol 57:517–522CrossRefPubMed
2.
Zurück zum Zitat Cai R, Li L, Liang X, Liu Z, Su L, Li W, Zhu Q, Mo Q, Pan L, Ouyang H, Huang L, Xu X (2002) Prevalence survey and molecular characterization of alpha and beta thalassemia in Liuzhou city of Guangxi. Zhonghua Liu Xing Bing Xue Za Zhi 23:281–285PubMed Cai R, Li L, Liang X, Liu Z, Su L, Li W, Zhu Q, Mo Q, Pan L, Ouyang H, Huang L, Xu X (2002) Prevalence survey and molecular characterization of alpha and beta thalassemia in Liuzhou city of Guangxi. Zhonghua Liu Xing Bing Xue Za Zhi 23:281–285PubMed
3.
Zurück zum Zitat Weatherall DJ, Clegg JB (2001) The thalassaemia syndromes, 4th edn. Blackwell Science, OxfordCrossRef Weatherall DJ, Clegg JB (2001) The thalassaemia syndromes, 4th edn. Blackwell Science, OxfordCrossRef
4.
Zurück zum Zitat Jia SQ, Li J, Mo QH, Liao C, Li LY, Xu XM (2004) Alpha0 thalassaemia as a result of a novel 11.1 kb deletion eliminating both of the duplicated alpha globin genes. J Clin Pathol 57:164–167CrossRefPubMed Jia SQ, Li J, Mo QH, Liao C, Li LY, Xu XM (2004) Alpha0 thalassaemia as a result of a novel 11.1 kb deletion eliminating both of the duplicated alpha globin genes. J Clin Pathol 57:164–167CrossRefPubMed
5.
Zurück zum Zitat Waye JS, Eng B, Chui DH (1992) Identification of an extensive zeta-alpha globin gene deletion in a Chinese individual. Br J Haematol 80:378–380CrossRefPubMed Waye JS, Eng B, Chui DH (1992) Identification of an extensive zeta-alpha globin gene deletion in a Chinese individual. Br J Haematol 80:378–380CrossRefPubMed
6.
Zurück zum Zitat Zhao JB, Zhao L, Fei YJ, Liu JC, Huisman TH (1991) A novel alpha-thalassemia-2 (-2.7-kb) observed in a Chinese patient with Hb H disease. Am J Hematol 38:248–249CrossRefPubMed Zhao JB, Zhao L, Fei YJ, Liu JC, Huisman TH (1991) A novel alpha-thalassemia-2 (-2.7-kb) observed in a Chinese patient with Hb H disease. Am J Hematol 38:248–249CrossRefPubMed
7.
Zurück zum Zitat Eng B, Walsh R, Walker L, Patterson M, Waye JS (2005) Characterization of a rare single alpha-globin gene deletion in a Chinese woman with Hb H disease. Hemoglobin 29:297–299CrossRefPubMed Eng B, Walsh R, Walker L, Patterson M, Waye JS (2005) Characterization of a rare single alpha-globin gene deletion in a Chinese woman with Hb H disease. Hemoglobin 29:297–299CrossRefPubMed
8.
Zurück zum Zitat Wang W, Ma ES, Chan AY, Prior J, Erber WN, Chan LC, Chui DH, Chong SS (2003) Single-tube multiplex-PCR screen for anti-3.7 and anti-4.2 alpha-globin gene triplications. Clin Chem 49:1679–1682CrossRefPubMed Wang W, Ma ES, Chan AY, Prior J, Erber WN, Chan LC, Chui DH, Chong SS (2003) Single-tube multiplex-PCR screen for anti-3.7 and anti-4.2 alpha-globin gene triplications. Clin Chem 49:1679–1682CrossRefPubMed
9.
Zurück zum Zitat Kimura EM, Grignoli CR, Pinheiro VR, Costa FF, Sonati MF (2003) Thalassemia intermedia as a result of heterozygosis for beta 0-thalassemia and alpha alpha alpha anti-3, 7 genotype in a Brazilian patient. Braz J Med Biol Res 36:699–701CrossRefPubMed Kimura EM, Grignoli CR, Pinheiro VR, Costa FF, Sonati MF (2003) Thalassemia intermedia as a result of heterozygosis for beta 0-thalassemia and alpha alpha alpha anti-3, 7 genotype in a Brazilian patient. Braz J Med Biol Res 36:699–701CrossRefPubMed
10.
Zurück zum Zitat Chui DH, Fucharoen S, Chan V (2003) Hemoglobin H disease: not necessarily a benign disorder. Blood 101:791–800CrossRefPubMed Chui DH, Fucharoen S, Chan V (2003) Hemoglobin H disease: not necessarily a benign disorder. Blood 101:791–800CrossRefPubMed
11.
Zurück zum Zitat Chen FE, Ooi C, Ha SY, Cheung BM, Todd D, Liang R, Chan TK, Chan V (2000) Genetic and clinical features of hemoglobin H disease in Chinese patients. N Engl J Med 343:544–550CrossRefPubMed Chen FE, Ooi C, Ha SY, Cheung BM, Todd D, Liang R, Chan TK, Chan V (2000) Genetic and clinical features of hemoglobin H disease in Chinese patients. N Engl J Med 343:544–550CrossRefPubMed
12.
Zurück zum Zitat Kanavakis E, Papassotiriou I, Karagiorga M, Vrettou C, Metaxotou-Mavrommati A, Stamoulakatou A, Kattamis C, Traeger-Synodinos J (2000) Phenotypic and molecular diversity of haemoglobin H disease: a Greek experience. Br J Haematol 111:915–923CrossRefPubMed Kanavakis E, Papassotiriou I, Karagiorga M, Vrettou C, Metaxotou-Mavrommati A, Stamoulakatou A, Kattamis C, Traeger-Synodinos J (2000) Phenotypic and molecular diversity of haemoglobin H disease: a Greek experience. Br J Haematol 111:915–923CrossRefPubMed
13.
Zurück zum Zitat Laosombat V, Viprakasit V, Chotsampancharoen T, Wongchanchailert M, Khodchawan S, Chinchang W, Sattayasevana B (2009) Clinical features and molecular analysis in Thai patients with HbH disease. Ann Hematol 88:1185–1192CrossRefPubMed Laosombat V, Viprakasit V, Chotsampancharoen T, Wongchanchailert M, Khodchawan S, Chinchang W, Sattayasevana B (2009) Clinical features and molecular analysis in Thai patients with HbH disease. Ann Hematol 88:1185–1192CrossRefPubMed
14.
Zurück zum Zitat Origa R, Sollaino MC, Giagu N, Barella S, Campus S, Mandas C, Bina P, Perseu L, Galanello R (2007) Clinical and molecular analysis of haemoglobin H disease in Sardinia: haematological, obstetric and cardiac aspects in patients with different genotypes. Br J Haematol 136:326–332CrossRefPubMed Origa R, Sollaino MC, Giagu N, Barella S, Campus S, Mandas C, Bina P, Perseu L, Galanello R (2007) Clinical and molecular analysis of haemoglobin H disease in Sardinia: haematological, obstetric and cardiac aspects in patients with different genotypes. Br J Haematol 136:326–332CrossRefPubMed
15.
Zurück zum Zitat Waye JS, Greenlay B, Eng B (2009) Novel 27.9 kb alpha(0)-thalassemia deletion in a Filipino woman. Am J Hematol 84:197–198CrossRefPubMed Waye JS, Greenlay B, Eng B (2009) Novel 27.9 kb alpha(0)-thalassemia deletion in a Filipino woman. Am J Hematol 84:197–198CrossRefPubMed
16.
Zurück zum Zitat Rugless MJ, Fisher CA, Old JM, Sloane-Stanley J, Ayyub H, Higgs DR, Garrick D (2008) A large deletion in the human alpha-globin cluster caused by a replication error is associated with an unexpectedly mild phenotype. Hum Mol Genet 17:3084–3093CrossRefPubMed Rugless MJ, Fisher CA, Old JM, Sloane-Stanley J, Ayyub H, Higgs DR, Garrick D (2008) A large deletion in the human alpha-globin cluster caused by a replication error is associated with an unexpectedly mild phenotype. Hum Mol Genet 17:3084–3093CrossRefPubMed
Metadaten
Titel
Molecular characterization of a novel 27.6-kb deletion causing α+ thalassemia in a Chinese family
verfasst von
Xiao-Feng Wei
Xuan Shang
De-Qin He
Ji-Wei Huang
Xin-Hua Zhang
Xiang-Min Xu
Publikationsdatum
01.01.2011
Verlag
Springer-Verlag
Erschienen in
Annals of Hematology / Ausgabe 1/2011
Print ISSN: 0939-5555
Elektronische ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-010-1030-1

Weitere Artikel der Ausgabe 1/2011

Annals of Hematology 1/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hodgkin Lymphom: BrECADD-Regime übertrifft die Erwartungen

05.06.2024 ASCO 2024 Kongressbericht

Das Kombinationsregime BrECADD mit Brentuximab vedotin ermöglichte in der Studie HD21 beim fortgeschrittenen klassischen Hodgkin-Lymphom eine unerwartet hohe progressionsfreie Überlebensrate von 94,3% nach vier Jahren. Gleichzeitig war das Regime besser tolerabel als der bisherige Standard eBEACOPP.

Antikörper-Drug-Konjugat verdoppelt PFS bei Multiplem Myelom

05.06.2024 ASCO 2024 Nachrichten

Zwei Phase-3-Studien deuten auf erhebliche Vorteile des Antikörper-Wirkstoff-Konjugats Belantamab-Mafodotin bei vorbehandelten Personen mit Multiplem Myelom: Im Vergleich mit einer Standard-Tripeltherapie wurde das progressionsfreie Überleben teilweise mehr als verdoppelt.

Neuer TKI gegen CML: Höhere Wirksamkeit, seltener Nebenwirkungen

05.06.2024 Chronische myeloische Leukämie Nachrichten

Der Tyrosinkinasehemmer (TKI) Asciminib ist älteren Vertretern dieser Gruppe bei CML offenbar überlegen: Personen mit frisch diagnostizierter CML entwickelten damit in einer Phase-3-Studie häufiger eine gut molekulare Response, aber seltener ernste Nebenwirkungen.

Hereditäres Angioödem: Tablette könnte Akuttherapie erleichtern

05.06.2024 Hereditäres Angioödem Nachrichten

Medikamente zur Bedarfstherapie bei hereditärem Angioödem sind bisher nur als Injektionen und Infusionen verfügbar. Der Arzneistoff Sebetralstat kann oral verabreicht werden und liefert vielversprechende Daten.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.